Roles of Vascular Smooth Muscle Cells in Atherosclerotic Calcification

키워드

참고문헌 (70)

1. Libby P, "Atherosclerosis", Nat Rev Dis Primers, 5, pp.56~ (2019)
2. Murray CJ, "Measuring the global burden of disease", N Engl J Med, 369, pp.448~457 (2013)
3. Bentzon JF, "Mechanisms of plaque formation and rupture", Circ Res, 114, pp.1852~1866 (2014)
4. Virmani R, "Lessons from sudden coronary death : a comprehensive morphological classification scheme for atherosclerotic lesions", Arterioscler Thromb Vasc Biol, 20, pp.1262~1275 (2000)
5. Basatemur GL, "Vascular smooth muscle cells in atherosclerosis", Nat Rev Cardiol, 16, pp.727~744 (2019)
6. Libby P, "Requiem for the ‘vulnerable plaque’", Eur Heart J, 36, pp.2984~2987 (2015)
7. Sugane H, "Cardiac outcomes in patients with acute coronary syndrome attributable to calcified nodule", Atherosclerosis, 318, pp.70~75 (2021)
8. Alexopoulos N, "Calcification in atherosclerosis", Nat Rev Cardiol, 6, pp.681~688 (2009)
9. Shi X, "Calcification in atherosclerotic plaque vulnerability : friend or foe?", Front Physiol, 11, pp.56~ (2020)
10. Sato Y, "Calcified nodule : a rare but important cause of acute coronary syndrome with worse clinical outcomes", Atherosclerosis, 318, pp.40~42 (2021)
11. Durham AL, "Role of smooth muscle cells in vascular calcification : implications in atherosclerosis and arterial stiffness", Cardiovasc Res, 114, pp.590~600 (2018)
12. Johnson RC, "Vascular calcification : pathobiological mechanisms and clinical implications", Circ Res, 99, pp.1044~1059 (2006)
13. Nakashima Y, "Early atherosclerosis in humans : role of diffuse intimal thickening and extracellular matrix proteoglycans", Cardiovasc Res, 79, pp.14~23 (2008)
14. Feil S, "Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis", Circ Res, 115, pp.662~667 (2014)
15. Jacobsen K, "Diverse cellular architecture of atherosclerotic plaque derives from clonal expansion of a few medial SMCs", JCI Insight, 2, pp.e95890~ (2017)
16. Pan H, "Single-cell genomics reveals a novel cell state during smooth muscle cell phenotypic switching and potential therapeutic targets for atherosclerosis in mouse and human", Circulation, 142, pp.2060~2075 (2020)
17. Shankman LS, "KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis", Nat Med, 21, pp.628~637 (2015)
18. Chappell J, "Extensive proliferation of a subset of differentiated, yet plastic, medial vascular smooth muscle cells contributes to neointimal formation in mouse injury and atherosclerosis models", Circ Res, 119, pp.1313~1323 (2016)
19. Alencar GF, "Stem cell pluripotency genes Klf4 and Oct4 regulate complex SMC phenotypic changes critical in late-stage atherosclerotic lesion pathogenesis", Circulation, 142, pp.2045~2059 (2020)
20. Kim JB, "Environment-sensing aryl hydrocarbon receptor inhibits the chondrogenic fate of modulated smooth muscle cells in atherosclerotic lesions", Circulation, 142, pp.575~590 (2020)
21. Wirka RC, "Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis", Nat Med, 25, pp.1280~1289 (2019)
22. Li S, "The serum response factor coactivator myocardin is required for vascular smooth muscle development", Proc Natl Acad Sci U S A, 100, pp.9366~9370 (2003)
23. Yoshida T, "Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes", Circ Res, 92, pp.856~864 (2003)
24. Yoshida T, "Role of Krüppel-like factor 4 and its binding proteins in vascular disease", J Atheroscler Thromb, 21, pp.402~413 (2014)
25. Yoshida T, "Krüppel-like factor 4 contributes to high phosphate-induced phenotypic switching of vascular smooth muscle cells into osteogenic cells", J Biol Chem, 287, pp.25706~25714 (2012)
26. Cherepanova OA, "Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective", Nat Med, 22, pp.657~665 (2016)
27. Nagao M, "Coronary disease-associated gene TCF21 inhibits smooth muscle cell differentiation by blocking the myocardin-serum response factor pathway", Circ Res, 126, pp.517~529 (2020)
28. Boettger T, "Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143", 145 gene cluster, 2009, pp.119, 2634~2647
29. Cordes KR, "miR-145 and miR-143 regulate smooth muscle cell fate and plasticity", Nature, 460, pp.705~710 (2009)
30. Mackenzie NC, "miRNA-221 and miRNA-222 synergistically function to promote vascular calcification", Cell Biochem Funct, 32, pp.209~216 (2014)
31. Gomez D, "Epigenetic control of smooth muscle cell identity and lineage memory", Arterioscler Thromb Vasc Biol, 35, pp.2508~2516 (2015)
32. Manabe I, "Recruitment of serum response factor and hyperacetylation of histones at smooth muscle-specific regulatory regions during differentiation of a novel P19-derived in vitro smooth muscle differentiation system", Circ Res, 88, pp.1127~1134 (2001)
33. Cao D, "Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin", Mol Cell Biol, 25, pp.364~376 (2005)
34. McDonald OG, "Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo", J Clin Invest, 116, pp.36~48 (2006)
35. Gomez D, "Detection of histone modifications at specific gene loci in single cells in histological sections", Nat Methods, 10, pp.171~177 (2013)
36. Mack CP, "Signaling mechanisms that regulate smooth muscle cell differentiation", Arterioscler Thromb Vasc Biol, 31, pp.1495~1505 (2011)
37. Wang Z, "Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression", Nature, 428, pp.185~189 (2004)
38. Davis BN, "Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype", J Biol Chem, 284, pp.3728~3738 (2009)
39. Deaton RA, "Sp1-dependent activation of KLF4 is required for PDGF-BB-induced phenotypic modulation of smooth muscle", Am J Physiol Heart Circ Physiol, 296, pp.H1027~H1037 (2009)
40. Tsaousi A, "The Wnt pathways in vascular disease : lessons from vascular development", Curr Opin Lipidol, 22, pp.350~357 (2011)
41. Cai T, "WNT", β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression, 2016, pp.345, 206~217
42. Qiu P, "Interaction of Smad3 and SRF-associated complex mediates TGF-β1 signals to regulate SM22 transcription during myofibroblast differentiation", J Mol Cell Cardiol, 35, pp.1407~1420 (2003)
43. Davis-Dusenbery BN, "down-regulation of Krüppel-like factor-4(KLF4)by microRNA-143", 145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-β and bone morphogenetic protein 4, 2011, pp.286, 28097~28110
44. Misra A, "Integrin beta3 regulates clonality and fate of smooth muscle-derived atherosclerotic plaque cells", Nat Commun, 9, pp.2073~ (2018)
45. Cheng SL, "Targeted reduction of vascular Msx1 and Msx2 mitigates arteriosclerotic calcification and aortic stiffness in LDLR-deficient mice fed diabetogenic diets", Diabetes, 63, pp.4326~4337 (2014)
46. Hofmann Bowman MA, "S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program", Arterioscler Thromb Vasc Biol, 31, pp.337~344 (2011)
47. Nakagawa Y, "Paracrine osteogenic signals via bone morphogenetic protein-2 accelerate the atherosclerotic intimal calcification in vivo", Arterioscler Thromb Vasc Biol, 30, pp.1908~1915 (2010)
48. Cheng SL, "Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-", -mice by restraining noncanonical Wnt signals, 2015, pp.117, 142~156
49. Woldt E, "The nuclear hormone receptor PPARγ counteracts vascular calcification by inhibiting Wnt5a signalling in vascular smooth muscle cells", Nat Commun, 3, pp.1077~ (2012)
50. Naik V, "Sources of cells that contribute to atherosclerotic intimal calcification : an in vivo genetic fate mapping study", Cardiovasc Res, 94, pp.545~554 (2012)
51. Kramann R, "Adventitial MSC-like cells are progenitors of vascular smooth muscle cells and drive vascular calcification in chronic kidney disease", Cell Stem Cell, 19, pp.628~642 (2016)
52. Wang H, "Sca1+ cells minimally contribute to smooth muscle cells in atherosclerosis", Circ Res, 128, pp.133~135 (2021)
53. Wu M, "TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease", Bone Res, 4, pp.16009~ (2016)
54. Abula K, "Elimination of BMP7 from the developing limb mesenchyme leads to articular cartilage degeneration and synovial inflammation with increased age", FEBS Lett, 589, pp.1240~1248 (2015)
55. Luu HH, "Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells", J Orthop Res, 25, pp.665~677 (2007)
56. Kanakaris NK, "Clinical applications of bone morphogenetic proteins : current evidence", J Surg Orthop Adv, 17, pp.133~146 (2008)[DOI]
57. Razzouk S, "BMP-2 : biological challenges to its clinical use", N Y State Dent J, 78, pp.37~39 (2012)
58. Noël D, "Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells", Stem Cells, 22, pp.74~85 (2004)
59. Gu K, "Identification of potential modifiers of Runx2", Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7, 2004, pp.176, 28~40
60. Shen B, "The role of BMP-7 in chondrogenic and osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in vitro", J Cell Biochem, 109, pp.406~416 (2010)
61. Tsuji K, "Conditional deletion of BMP7 from the limb skeleton does not affect bone formation or fracture repair", J Orthop Res, 28, pp.384~389 (2010)
62. Kokabu S, "BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b", Mol Endocrinol, 26, pp.87~94 (2012)
63. Miyazawa K, "Regulation of TGF-β family signaling by inhibitory Smads", Cold Spring Harb Perspect Biol, 9, pp.a022095~ (2017)
64. Rodríguez-Carballo E, "p38 MAPK signaling in osteoblast differentiation", Front Cell Dev Biol, 4, pp.40~ (2016)
65. Abe E, "Essential requirement of BMPs-2", 4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice : antagonism by noggin, 2000, pp.15, 663~673
66. Gazzerro E, "Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts", J Clin Invest, 102, pp.2106~2114 (1998)
67. Wan DC, "Noggin suppression enhances in vitro osteogenesis and accelerates in vivo bone formation", J Biol Chem, 282, pp.26450~26459 (2007)
68. Shimada K, "Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells", Bone, 42, pp.886~893 (2008)
69. Yukita A, "Ubc9 negatively regulates BMP-mediated osteoblastic differentiation in cultured cells", Bone, 50, pp.1092~1099 (2012)
70. Woo SH, "TXNIP suppresses the osteochondrogenic switch of vascular smooth muscle cells in atherosclerosis", Circ Res, 132, pp.52~71 (2023)

관련 논문AI추천